IGF2BP2 and pancreatic neoplasm: CircMYO1 is upregulated in pancreatic cancer and stabilizes m6A‐modified PD‐L1 mRNA with IGF2BP2 to upregulate PD‐L1 expression, promoting immune escape [32].